Evidence map›Paper›PMID 23241648›Full record

ArticlePsychopharmacology2013

Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Tristan J Watkins, Vidya Raj, Junghee Lee, Mary S Dietrich, Aize Cao, Jennifer U Blackford, Ronald M Salomon, Sohee Park, Margaret M Benningfield, Christina R Di Iorio and 1 more

Abstract read
In one paragraph

Article in Psychopharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tristan J WatkinsVanderbilt Addiction Center, Vanderbilt University School of Medicine, Nashville, TN 37212, USA. tristan.j.watkins@vanderbilt.edu
Vidya Raj
Junghee Lee
Mary S Dietrich
Aize Cao
Jennifer U Blackford
Ronald M Salomon
Sohee Park
Margaret M Benningfield
Christina R Di Iorio
Ronald L Cowan

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
AACAP Physician Scientist Program in Substance UseK12DA000357 · NIDA · AMERICAN ACADEMY-CHILD/ADOLESCENT PSYCH · PI Kevin M. Gray · 1998 to 2026
$29.1M
The Vanderbilt Institute for Clinical and Translational Research (VICTR) KL2KL2RR024977 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$3.0M
The Vanderbilt Institute for Clinical and Translational Research (VICTR) TL1TL1RR024978 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$1.3M
MR Analysis of Persistent CNS Damage in Human MDMA UsersR01DA015137 · NIDA · VANDERBILT UNIVERSITY · PI COWAN, RONALD L · 2004 to 2006
$1.1M
Neuroimaging and Genetic Study of Inhibited TemperamentK01MH083052 · NIMH · VANDERBILT UNIVERSITY · PI BLACKFORD, JENNIFER URBANO · 2008 to 2012
$718k
Spectral Features of Raphe fMRI Time Series Data in DepressionR21MH087803 · NIMH · VANDERBILT UNIVERSITY · PI SALOMON, RONALD MURRAY · 2010 to 2011
$423k
Genetic Factors in Human MDMA Toxicity: A PET StudyR21DA020149 · NIDA · VANDERBILT UNIVERSITY · PI COWAN, RONALD L · 2007 to 2008
$418k
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1TR000445NCRR NIH HHS KL2 RR024977NCRR NIH HHS TL1 RR024978NCRR NIH HHS UL1 RR024975NIAAA NIH HHS L30 AA019909NIDA NIH HHS K12 DA000357NIDA NIH HHS K12 DA00357NIDA NIH HHS R01 DA015137NIDA NIH HHS R21 DA020149NIMH NIH HHS K01 MH083052NIMH NIH HHS R21 MH087803NIMH NIH HHS R21MH087803-02
6 · The paper itself

Abstract

rationaleEcstasy (3,4-methylenedioxymethamphetamine [MDMA]) polydrug users have verbal memory performance that is statistically significantly lower than that of control subjects. Studies have correlated long-term MDMA use with altered brain activation in regions that play a role in verbal memory.

objectivesThe aim of our study was to examine the association of lifetime ecstasy use with semantic memory performance and brain activation in ecstasy polydrug users.

methodsA total of 23 abstinent ecstasy polydrug users (age = 24.57 years) and 11 controls (age = 22.36 years) performed a two-part functional magnetic resonance imaging (fMRI) semantic encoding and recognition task. To isolate brain regions activated during each semantic task, we created statistical activation maps in which brain activation was greater for word stimuli than for non-word stimuli (corrected p < 0.05).

resultsDuring the encoding phase, ecstasy polydrug users had greater activation during semantic encoding bilaterally in language processing regions, including Brodmann areas 7, 39, and 40. Of this bilateral activation, signal intensity with a peak T in the right superior parietal lobe was correlated with lifetime ecstasy use (r s = 0.43, p = 0.042). Behavioral performance did not differ between groups.

conclusionsThese findings demonstrate that ecstasy polydrug users have increased brain activation during semantic processing. This increase in brain activation in the absence of behavioral deficits suggests that ecstasy polydrug users have reduced cortical efficiency during semantic encoding, possibly secondary to MDMA-induced 5-HT neurotoxicity. Although pre-existing differences cannot be ruled out, this suggests the possibility of a compensatory mechanism allowing ecstasy polydrug users to perform equivalently to controls, providing additional support for an association of altered cerebral neurophysiology with MDMA exposure.

Indexed as

SemanticsAdolescentAdultBrainFemaleHumansIllicit DrugsMagnetic Resonance ImagingMaleMemoryN-Methyl-3,4-methylenedioxyamphetamineProspective StudiesPsychomotor PerformanceYoung AdultIllicit DrugsN-Methyl-3,4-methylenedioxyamphetamine

Identifiers

PMID23241648
PMCPMC3615064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.